Acute Respiratory Distress Syndrome (ARDS) Clinical Trial
— APRONETOfficial title:
Prospective Study on the Prevalence on the Use of Prone Positioning in ARDS Patients
Verified date | March 2018 |
Source | Hospices Civils de Lyon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Prone positioning has been shown to improve survival in patients with acute respiratory
distress syndrome (ARDS). However, a recent large observational study found that prone
positioning was used in only 7% of all ARDS patients, and 16% in the severe category.
However, this study did not focus on the prone position per se. In present study, the
investigators would like to explore the rate of use of prone positioning in ARDS patients and
the reasons why this treatment was not applied. The present study is one-day prevalence study
repeated four times over one year.
The hypothesis is that the rate of use of prone position is greater than 50% in the severe
ARDS category.
Status | Completed |
Enrollment | 736 |
Est. completion date | January 2017 |
Est. primary completion date | January 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 1.ARDS criteria (Berlin definition) fulfilled the day of the study, whatever the ARDS stage. The onset of ARDS could have been established at any time between ICU admission and study day but ARDS criteria must be still present the day of the study. The ARDS criteria are listed below - Within 1 week of a known clinical insult or new or worsening respiratory symptoms - Bilateral opacities—not fully explained by effusions, lobar/lung collapse, or nodules - Respiratory failure not fully explained by cardiac failure or fluid overload. Need objective assessment (eg, echocardiography) to exclude hydrostatic edema if no risk factor present - 2.PaO2/FIO2 = 300 with PEEP = 5 cmH2O - 3.Age = 18 years - 4.Intubated or tracheotomized and mechanically ventilated Exclusion Criteria: - Patient non intubated the day of the study - No criteria for ARDS the day of the study even if these criteria were present between ICU admission and day of the study |
Country | Name | City | State |
---|---|---|---|
France | Réanimation médicale, Hôpital de la Croix Rousse, CHU de Lyon, France | Lyon |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Prevalence of the use of the prone position in ARDS | Number of patients with ARDS receiving prone position divided by number of patients with ARDS on the day of the study | Day 1 | |
Secondary | Prevalence of the use of the prone position in each ARDS category | Number of patients with ARDS in each category receiving prone position divided by number of patients with ARDS in each category on the day of the study | Day 1 | |
Secondary | Occurence of reasons for not using prone position in ARDS patients | Reasons: No severe hypoxemia for the clinician, Intracranial hypertension, Mean arterial pressure < 65 mmHg, Unstable fractures, Pneumothorax with previous single drain, External cardiac stimulation or internal pacemaker inserted for less than 48 hours, Tracheotomy for less than 15 days (not for access to airways for the current mechanical ventilation purpose), Severe facial trauma or facial surgery in the last 15 days, Sternotomy in the last 15 days, Venous thrombosis treated by anticoagulant molecule for less than 48 hours, Massive hemoptysis requiring interventional radiology or other emergency procedure, Pregnant woman, Excess in workload, Other reason | Day 1 | |
Secondary | PaO2 | oxygenation (PaO2) to assess the physiological response to the prone position session | Day 1 | |
Secondary | PaO2/FIO2 | oxygenation (PaO2/FIO2) to assess the physiological response to the prone position session | Day 1 | |
Secondary | Duration of prone position session | Difference between time of onset to time of end (consecutive hours) | Day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03909854 -
Pragmatic Investigation of Volume Targeted Ventilation-1
|
N/A | |
Recruiting |
NCT02637011 -
Surviving ARDS: The Influence of Quality of Care and Individual Patient Characteristics on Quality of Life
|
N/A | |
Completed |
NCT02288949 -
Stratification of the Acute Respiratory Distress Syndrome
|
||
Recruiting |
NCT02574169 -
Alveolar Recruitment Maneuvers, Intracerebral Hemodynamic and Oxygenation
|
N/A | |
Completed |
NCT04548739 -
Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)
|
||
Completed |
NCT05024500 -
Clinical and Functional Outcomes of Critically Ill Patients With COVID-19
|
N/A | |
Terminated |
NCT04511650 -
Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019
|
Phase 2 | |
Recruiting |
NCT01339533 -
Airway Pressure Release Ventilation (APRV) Versus AC/VC Conventional Ventilation
|
Phase 2 | |
Active, not recruiting |
NCT01274260 -
Trial of Steroids in Pediatric Acute Lung Injury/ARDS
|
Phase 2 | |
Recruiting |
NCT03296059 -
Transfusion of Red Blood Cells for Acute Respiratory Distress Syndrome(ARDS) in Neonates
|
N/A | |
Terminated |
NCT04609865 -
Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia
|
Phase 3 | |
Active, not recruiting |
NCT04009330 -
Clinical Evaluation of a Point of Care (POC) Assay to Identify Phenotypes in the Acute Respiratory Distress Syndrome
|
||
Not yet recruiting |
NCT06127381 -
An Open-label Study of the Safety and Pharmacokinetics of the TGKP
|
Phase 1 | |
Not yet recruiting |
NCT05847517 -
Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
|
Phase 3 | |
Completed |
NCT01854424 -
Validation of the Percentage of Alveolar Fibrocyte as Biomarker During ARDS
|
N/A | |
Completed |
NCT03870009 -
Validation of a Semi-automatized Method to Detect Cyclic Hyperinflation on CT-scan in ARDS
|
N/A | |
Completed |
NCT04311697 -
Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
|
Phase 2/Phase 3 | |
Recruiting |
NCT02095444 -
Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection
|
Phase 1/Phase 2 | |
Recruiting |
NCT04460859 -
RecruitmEnt Assessed by eleCtRical Impedance Tomography
|
||
Completed |
NCT01926093 -
Low Dose Lung CT Scan for Quantitative Analysis in ARDS Patients
|
N/A |